REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,312,741 | +8.8% | 201,634 | +140.0% | 0.02% | 0.0% |
| Q2 2023 | $2,126,040 | +20.0% | 84,000 | +52.7% | 0.02% | +5.9% |
| Q1 2023 | $1,771,582 | -44.0% | 55,001 | -67.9% | 0.02% | -34.6% |
| Q4 2022 | $3,163,139 | -46.0% | 171,351 | -21.0% | 0.03% | -46.9% |
| Q3 2022 | $5,857,000 | +1899.0% | 216,899 | +2090.9% | 0.05% | +1533.3% |
| Q2 2021 | $293,000 | -88.6% | 9,900 | -88.2% | 0.00% | -98.4% |
| Q1 2018 | $2,578,000 | -24.4% | 83,700 | -12.2% | 0.19% | -30.8% |
| Q4 2017 | $3,409,000 | – | 95,357 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |